DrugPatentWatch Database Preview

Rolapitant hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for rolapitant hydrochloride and what is the scope of rolapitant hydrochloride freedom to operate?

Rolapitant hydrochloride is the generic ingredient in one branded drug marketed by Tersera Theraps Llc and is included in two NDAs. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Rolapitant hydrochloride has one hundred and fifty-three patent family members in thirty-four countries.

One supplier is listed for this compound.

Summary for rolapitant hydrochloride

International Patents:	153
US Patents:	9
Tradenames:	1
Applicants:	1
NDAs:	2
Suppliers / Packagers:	1
Bulk Api Vendors:	40
Clinical Trials:	12
Patent Applications:	42
DailyMed Link:	rolapitant hydrochloride at DailyMed

Pharmacology for rolapitant hydrochloride

Drug Class	Substance P/Neurokinin-1 Receptor Antagonist
Mechanism of Action	Neurokinin 1 Antagonists Cytochrome P450 2D6 Inhibitors Breast Cancer Resistance Protein Inhibitors P-Glycoprotein Inhibitors

Synonyms for rolapitant hydrochloride

(5S,8S)-8-(((1R)-1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro(4.5)decan-2-one monohydrochloride monohydrate

(5S,8S)-8-(((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one

(5S,8S)-8-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-2-oxo-8-phenyl-1,7-diazaspiro[4.5]decan-7-ium chloride

(5S,8S)-8-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-2-oxo-8-phenyl-1,7-diazaspiro[4.5]decan-7-ium chloride--water (1/1)

(5S,8S)-8-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one

(5S,8S)-8-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one hydrochloride

(5S,8S)-8-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one hydrochloride--water (1/1)

(5S,8S)-8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,9-diazaspiro[4.5]decan-2-one

1-Methyl-4-[3-(5-nitro-2-furanyl)-1-oxo-2-propenyl]-piperazine

1,7-Diazaspiro(4.5)decan-2-one, 8-(((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-, monohydrochloride, (5S,8S)-

1,7-Diazaspiro(4.5)decan-2-one, 8-(((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-, monohydrochloride, monohydrate, (5S,8S)-

552292-08-7

57O5S1QSAQ

858102-79-1

914462-92-3

943029-75-2

AKOS027250926

AKOS030234023

API0014111

B5910

BC600524

bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,9-diazaspiro[4.5]decan-2-one

CHEBI:90908

CHEBI:90911

CHEBI:90912

CHEMBL3707330

CHEMBL3707331

CS-6387

D08988

D0CF0Y

D10742

DB09291

DTXSID40235091

DTXSID70238570

DTXSID90203740

EX-A1288

FT-0700330

GTPL5749

HY-14751

J-690322

J7Z9DBN8J0

MFCD23105917

MolPort-035-942-975

MolPort-044-567-688

NLE429IZUC

PB37313

Q-4560

QC-11703

Rolapitant

Rolapitant (USAN/INN)

Rolapitant [USAN:INN]

Rolapitant HCl

rolapitant hydrochloride (anhydrous)

Rolapitant hydrochloride (USAN)

Rolapitant hydrochloride [USAN]

Rolapitant hydrochloride anhydrous

Rolapitant hydrochloride hydrate

rolapitant monohydrochloride

rolapitant monohydrochloride monohydrate

rolapitant.HCl

rolapitant.HCl.H2O

Rolapitant(sch619734)

Sch 619734

SCH-619734

SCH619734

SCHEMBL2173125

SCHEMBL354305

UNII-57O5S1QSAQ

UNII-J7Z9DBN8J0

UNII-NLE429IZUC

Varubi

Varubi (TN)

ZINC3816514

US Patents and Regulatory Information for rolapitant hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Tersera Theraps Llc	VARUBI	rolapitant hydrochloride	EMULSION;INTRAVENOUS	208399-001	Oct 25, 2017		DISCN	Yes	No
Tersera Theraps Llc	VARUBI	rolapitant hydrochloride	EMULSION;INTRAVENOUS	208399-001	Oct 25, 2017		DISCN	Yes	No
Tersera Theraps Llc	VARUBI	rolapitant hydrochloride	EMULSION;INTRAVENOUS	208399-001	Oct 25, 2017		DISCN	Yes	No
Tersera Theraps Llc	VARUBI	rolapitant hydrochloride	TABLET;ORAL	206500-001	Sep 1, 2015		RX	Yes	Yes
Tersera Theraps Llc	VARUBI	rolapitant hydrochloride	TABLET;ORAL	206500-001	Sep 1, 2015		RX	Yes	Yes			Y	Y
Tersera Theraps Llc	VARUBI	rolapitant hydrochloride	TABLET;ORAL	206500-001	Sep 1, 2015		RX	Yes	Yes			Y

International Patents for rolapitant hydrochloride

Country	Document Number	Estimated Expiration
Peru	05452012
Japan	2009532473
Japan	2014058549
World Intellectual Property Organization (WIPO)	2007114921
Chile	2008000819
Poland	370841

Supplementary Protection Certificates for rolapitant hydrochloride

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2017000080	Germany		PRODUCT NAME: ROLAPITANT, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES, EINSCHLIESSLICH ROLAPITANT HYDROCHLORID-MONOHYDRAT; REGISTRATION NO/DATE: EU/1/17/1180 20170420
2017032	Lithuania		PRODUCT NAME: ROLAPITANTAS, PASIRINKTINAI FARMACINIU POZIURIU PRIIMTINOS DRUSKOS FORMOS, ISKAITANT ROLAPITANTO HIDROCHLORIDO MONOHIDRATA; REGISTRATION NO/DATE: EU/1/17/1180/001 20170420
2017 00041	Denmark		PRODUCT NAME: ROLAPITANT, EVENTUELT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT, INKLUSIV ROLAPITANT-HYDROCHLORID-MONOHYDRAT; REG. NO/DATE: EU/1/17/1180 20170424
0895	Netherlands		PRODUCT NAME: ROLAPITANT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, MET INBEGRIP VAN ROLAPITANT HYDROCHLORIDEMONOHYDRAAT; REGISTRATION NO/DATE: EU/1/17/1180/001 20170424
2017000079	Germany		PRODUCT NAME: ROLAPITANT HYDROCHLORID-MONOHYDRAT; REGISTRATION NO/DATE: EU/1/17/1180 20170420
2017031	Lithuania		PRODUCT NAME: ROLAPITANTO HIDROCHLORIDO MONOHIDRATAS; REGISTRATION NO/DATE: EU/1/17/1180/001 20170420